Ten Largest Investments
Summary by AI BETAClose X
JPMorgan European Growth & Income PLC announced its ten largest investments as of September 30, 2025. The largest holding is in ASML, representing 3.9% of total assets, followed by Novartis at 3.4% and SAP at 3.1%. Roche Holdings accounts for 2.9%, Siemens for 2.7%, and Nestle for 2.5%. The company also holds a 2.4% stake in JPMorgan European Discovery Trust Plc, 2.3% in both Unicredit SPA and Allianz, and 2.2% in Safran SA. Collectively, these ten investments represent 27.7% of the company's total assets, excluding investments in liquidity stocks.
JPMorgan European Grwth & Inc PLC
14 October 2025
|
JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 30 September 2025 |
|
|
Asml |
3.9% |
|
Novartis |
3.4% |
|
Sap |
3.1% |
|
Roche Holdings |
2.9% |
|
Siemens |
2.7% |
|
Nestle |
2.5% |
|
JPMorgan European Discovery Trust Plc |
2.4% |
|
Unicredit SPA |
2.3% |
|
Allianz |
2.3% |
|
Safran Sa |
2.2% |
|
Total |
27.7% |
|
Excludes Investments in Liquidity stocks |
|
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
|
Date: 14 October 2025 |
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund